Portal:Disease/BlauBookPathways
From WikiPathways
(Difference between revisions)
| Line 31: | Line 31: | ||
* [[Pathway:WP4236]] - Chapter 20 "Disorders of the Krebs Cycle" | * [[Pathway:WP4236]] - Chapter 20 "Disorders of the Krebs Cycle" | ||
| - | * [[Pathway:WP4153]] - Chapter 25 "Lysosomal Storage Disorders Including Neuronal Ceroid Lipofuscinoses" | + | * [[Pathway:WP4153]] - Chapter 25 "Lysosomal Storage Disorders Including Neuronal Ceroid Lipofuscinoses (Sphingolipid degradation)" |
* [[Pathway:WP4220]] - Chapter 31 "Neurotransmitter Disorders" | * [[Pathway:WP4220]] - Chapter 31 "Neurotransmitter Disorders" | ||
| Line 39: | Line 39: | ||
{| style="margin: 10px" | {| style="margin: 10px" | ||
|width=100px; cell padding=50px|{{#pwImage:Pathway:WP4236|250px||Disorders of the Krebs Cycle}} | |width=100px; cell padding=50px|{{#pwImage:Pathway:WP4236|250px||Disorders of the Krebs Cycle}} | ||
| - | |width=100px|{{#pwImage:Pathway:WP4153|250px||Lysosomal Storage Disorders Including Neuronal Ceroid Lipofuscinoses}} | + | |width=100px|{{#pwImage:Pathway:WP4153|250px||Lysosomal Storage Disorders Including Neuronal Ceroid Lipofuscinoses (Sphingolipid degradation)}} |
|width=100px|{{#pwImage:Pathway:WP4220|250px||Neurotransmitter Disorders}} | |width=100px|{{#pwImage:Pathway:WP4220|250px||Neurotransmitter Disorders}} | ||
|width=100px|{{#pwImage:Pathway:WP4224|250px||Purine Disorders}} | |width=100px|{{#pwImage:Pathway:WP4224|250px||Purine Disorders}} | ||
|width=100px|{{#pwImage:Pathway:WP4225|250px||Pyrimidine Disorders}} | |width=100px|{{#pwImage:Pathway:WP4225|250px||Pyrimidine Disorders}} | ||
|} | |} | ||
Revision as of 15:49, 8 February 2019
- Pathway:WP4156 - Chapter 1 "Disorders of Phenylalanine and Tetrahydrobiopterin (BH4) Metabolism"
- Pathway:WP4506 - Chapter 2 "Tyrosine Metabolism"
- Pathway:WP4292 - Chapter 3 "Sulphur Amino Acids"
- Pathway:WP4259 - Chapter 10 "Disorders of Folate Metabolism and Transport"
- Pathway:WP4288 - Chapter 10 "MTHFR deficiency (additional pathway)"
|
Image does not exist Disorders of Phenylalanine and Tetrahydrobiopterin (BH4) Metabolism |
Image does not exist Tyrosine Metabolism |
Image does not exist Sulphur Amino Acids |
Image does not exist Disorders of Folate Metabolism and Transport |
Image does not exist MTHFR deficiency (additonal pathway) |
- Pathway:WP4228 - Chapter 11 "Vitamine B6-Dependent and Responsive Disorders"
- Pathway:WP4507 - Chapter 12 "Molybdenum (Moco) cofactor biosynthesis"
- Pathway:WP4504 - Chapter 12 "Cysteine and Methionine catabolism"
- Pathway:WP4271 - Chapter 13 "Vitamin B12 Disorders"
- Pathway:WP4297 - Chapter 15 "Thiamine Disorders"
|
Image does not exist Vitamine B6-Dependent and Responsive Disorders |
Image does not exist Molybdenum (Moco) cofactor biosynthesis |
Image does not exist Cysteine and Methionine catabolism |
Image does not exist Vitamin B12 Disorders |
Image does not exist Thiamine Disorders |
- Pathway:WP4236 - Chapter 20 "Disorders of the Krebs Cycle"
- Pathway:WP4153 - Chapter 25 "Lysosomal Storage Disorders Including Neuronal Ceroid Lipofuscinoses (Sphingolipid degradation)"
- Pathway:WP4220 - Chapter 31 "Neurotransmitter Disorders"
- Pathway:WP4224 - Chapter 41 "Purine Disorders"
- Pathway:WP4225 - Chapter 41 "Pyrimidine Disorders"
|
Image does not exist Disorders of the Krebs Cycle |
Image does not exist Lysosomal Storage Disorders Including Neuronal Ceroid Lipofuscinoses (Sphingolipid degradation) |
Image does not exist Neurotransmitter Disorders |
Image does not exist Purine Disorders |
Image does not exist Pyrimidine Disorders |
